Scientist in lab

A Bench-to-Bedside Model

One of the unique hallmarks of Mount Sinai is the close proximity of our research and clinical enterprises. Scientific discoveries can reach the bedsides of patients at speed and scale, just as clinical insights inform and accelerate research. 

This is the foundation that has established Mount Sinai as a leading academic medical center and advanced the world’s understanding of human health—with philanthropy powering the Centers, Institutes, and projects that are shaping the science of the future.

A Decade of Discovery for Alzheimer's Disease

Nearly 7 million Americans have Alzheimer's disease, a number that is expected to rise to 13 million by 2050. On its 10th anniversary, the Ronald M. Loeb Center looked at the progress that has been made and the potential for new discoveries to come.

Watch video
a gloved hand pointing at brain scans on a computer screen

AI Is Changing Research and More at Mount Sinai

Mount Sinai established the first department for artificial intelligence in the nation and is also pioneering genetic sequencing of soon-to-be a million patients and introducing a new approach to personalized medicine. See how we are harnessing technology and reaching new frontiers of research with real-world applications.

Watch video
a demonstration of AI with a hand and screen

Philanthropy and Research

Bat Mitzvah Vivian surrounded by family
Swimming for a Cause: A Bat Mitzvah Fundraiser for Long COVID Awareness
cancer video still
A New Era in Lung Cancer Treatment and Diagnosis
Doctor using AI tools
Harnessing Artificial Intelligence at the Mount Sinai Health System
Natalie Rasgon, MD, PhD
Two Wellcome Leap Funding Contracts Accelerate Women’s Health Research
Bob Parsons cutting the ribbon of the new center in his name
How a Decorated Marine Continues His Military Service in an Unlikely Way
Dr. Tewari and the events honorees pose at the gala
Annual Prostate Cancer Gala Advances Research and Builds Community

A Transformative Gift for Translational Research

CADASIL is a cerebral small-vessel disease that has no available treatment. A physician-scientiest, her patient, an entrepreneurially-minded foundation, and a close friendship have come together to address the major gaps in the drug development pipeline and develop an effective treatment.

Read more
Jeff Green and Steve Katelman
Bold Approaches

An Accelerator for the Boldest Ideas

When the Friedman Brain Institute (FBI) Research Scholars Program launched in 2016, its goal was to secure early-stage funding for novel ideas and daring nascent brain research projects.

Read more